World's First Use of CAD as Primary Reader in Ground-Breaking Colon Cancer Screening Project
By MedImaging International staff writers Posted on 03 Sep 2008 |
Approximately 26,000 residents within Italy's Piedmont region will be involved in Protèus, the first program in the world to use computer-aided detection (CAD) to screen patients for colon cancer, as part of the Italian province's cancer prevention efforts.
The program is being launched in Turin, Italy, and is sponsored by the region of Piedmont, im3D-Medical Imaging Lab (Turin, Italy), the University of Turin (Interdepartmental Center for Molecular Biotechnology and the department of medical surgery disciplines-- radiology section), CPO (Center for Epidemiology and Oncology Prevention; Piedmont, Italy), and CIS Piedmont. The project allocates EUR 4.7 million over two years to test the innovative diagnostic methodology, CAD, as a primary screening protocol and emphasizes the use of technologic innovation applied to prevention.
Protéus features CAD-Colon, a fast, intuitive and extremely accurate diagnostic system developed as the result of over six years of interdisciplinary medical and scientific research conducted by im3D--Medical Imaging Lab, together with its clinical and scientific partners, which include IRCC-Institute for Cancer Research and Treatment (Candiolo, Italy). The experimental screening project forges a strong collaboration between diagnostic imaging for oncology and chemistry, represented by im3D and the University of Turin's Interdepartmental Center for Molecular Biotechnology, through which the parties intend to advance oncology research and prevention of the pathology.
The experiment is expected to validate the high diagnostic performance levels already obtained within preliminary studies using CAD-COLON, which have primarily addressed its sensitivity and specificity. Verification of the methodology means that it can then be applied to large-scale screening projects as well as to other pathologies. In fact, the project calls for the construction of a "Telediagnosis Center for Prevention,” which will centralize the collection and aggregation of data, optimize costs, and play an enormous role in leveraging expertise and data exchange for research purposes.
Specific objectives of the project include to test an innovative new prevention methodology that is less invasive and highly precise; to increase the effectiveness of colon cancer prevention, the second highest cancer-related cause of death worldwide, by increasing the percentage of the population willing to submit to a "more friendly” exam; to create value and know-how both in terms of the utilization of CAD technology for cancer screening, and the use of telediagnosis for a more rapid and effective diagnostic process; to create a framework for the construction of an "Center for Experimentation of New Technologies for the Medical Sector,” with the aim to become a point of reference both nationally and internationally; and lastly to disseminate scientific, medical, and technologic knowledge to help the fight against cancer.
im3D is a research center that collaborates closely with medical and clinical specialists to develop advanced medical imaging solutions for the early detection and prevention of cancer pathologies.
Related Links:
im3D-Medical Imaging Lab
The program is being launched in Turin, Italy, and is sponsored by the region of Piedmont, im3D-Medical Imaging Lab (Turin, Italy), the University of Turin (Interdepartmental Center for Molecular Biotechnology and the department of medical surgery disciplines-- radiology section), CPO (Center for Epidemiology and Oncology Prevention; Piedmont, Italy), and CIS Piedmont. The project allocates EUR 4.7 million over two years to test the innovative diagnostic methodology, CAD, as a primary screening protocol and emphasizes the use of technologic innovation applied to prevention.
Protéus features CAD-Colon, a fast, intuitive and extremely accurate diagnostic system developed as the result of over six years of interdisciplinary medical and scientific research conducted by im3D--Medical Imaging Lab, together with its clinical and scientific partners, which include IRCC-Institute for Cancer Research and Treatment (Candiolo, Italy). The experimental screening project forges a strong collaboration between diagnostic imaging for oncology and chemistry, represented by im3D and the University of Turin's Interdepartmental Center for Molecular Biotechnology, through which the parties intend to advance oncology research and prevention of the pathology.
The experiment is expected to validate the high diagnostic performance levels already obtained within preliminary studies using CAD-COLON, which have primarily addressed its sensitivity and specificity. Verification of the methodology means that it can then be applied to large-scale screening projects as well as to other pathologies. In fact, the project calls for the construction of a "Telediagnosis Center for Prevention,” which will centralize the collection and aggregation of data, optimize costs, and play an enormous role in leveraging expertise and data exchange for research purposes.
Specific objectives of the project include to test an innovative new prevention methodology that is less invasive and highly precise; to increase the effectiveness of colon cancer prevention, the second highest cancer-related cause of death worldwide, by increasing the percentage of the population willing to submit to a "more friendly” exam; to create value and know-how both in terms of the utilization of CAD technology for cancer screening, and the use of telediagnosis for a more rapid and effective diagnostic process; to create a framework for the construction of an "Center for Experimentation of New Technologies for the Medical Sector,” with the aim to become a point of reference both nationally and internationally; and lastly to disseminate scientific, medical, and technologic knowledge to help the fight against cancer.
im3D is a research center that collaborates closely with medical and clinical specialists to develop advanced medical imaging solutions for the early detection and prevention of cancer pathologies.
Related Links:
im3D-Medical Imaging Lab
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more